SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Technology Stocks : Osicom(FIBR) -- Ignore unavailable to you. Want to Upgrade?


To: Robert Gordon who wrote (6036)3/20/1998 9:12:00 AM
From: Stewart V. Nelson  Read Replies (1) | Respond to of 10479
 
Robert
Here is the entire e-mail. I sent Brooks the post by Market Mover.

At 10:57 AM 3/19/98 -0800, you wrote:
>The following post was made on Silicon Investor. Can you comment on its'
>accuracy?
>
>To: David Pawlak (5985 )
>From: marketmover Thursday, Mar 19 1998 1:17PM EST
>
>David P. -- thanks for the email
>Question:
>Has Brooks confirmed that Gigamux is "approved" for deployment?
>I know for a fact that the "test" of the Gigamux at the Brooks lab was
>only a publicity stunt staged by Osicom. Osicom paid the Brooks-affiliated
>lab for use of its test equipment and, at the time of the (fraudulent)
>press release, Brooks had no corporate relationship with FIBR. (The NASA
>lab, Dynacs, told me the same story.)
>Also is there any proof that this RTC and BBV are real?
>Please reply.
>
>Does Brooks have any corporate relationship to Osicom?
>Thanks
>Stewart V. Nelson
>Snelson@izzy.net

Osicom passed Phase I testing with a BER of 10 to the -14 over a period of ninety days.

Our lab does not have any corporate affiliation with any of the vendors tested in the National Data Systems Research Lab in Stockton, CA. Prior to approval, the Gigamux must pass the second phase of the trial within the Dallas, TX metropolitan area network.

Please note that testing has not progressed to live customer trials yet and Dr. Hrubes has not approved the Gigamux for network deployment. The initial trial was encouraging but not conclusive. There were many outstanding issues regarding SNMP management, completion of drop-and-insert, and additional wave length.

Thank-you for your inquiry.